Signaling Pathways - F1 Fo-ATPase - HCV polymerase - Hedgehog - MK2
清除全部
- C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂
- B3041 BTB06584Target: F1 Fo-ATPaseSummary: F1F0 ATP合酶抑制剂
- A3738 PSI-7977中文名: 索非布韦,索氟布韦Target: HCV polymeraseSummary: 慢性丙型肝炎病毒(HCV)感染的抗病毒剂
- A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂
- A4032 VX-222 (VCH-222, Lomibuvir)Target: HCV polymeraseSummary: HCV RNA聚合酶抑制剂
- A3021 GDC-0449 (Vismodegib)1 Citation中文名: 维莫德吉Target: P-glycoprotein (P-gp)|HedgehogSummary: Hedgehog拮抗剂
- A8189 PSI-62063 CitationTarget: HCV polymeraseSummary: HCV RNA聚合酶抑制剂